Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | -550,00 | 135,60k | Verkauf | 246,54 | 346,00 | -61,38% |
| 2026-04-24 | Mr. Roop K. LakkarajuExec. VP & CFO | -420,00 | 120,89k | Derivative Exercise and Sale | 287,84 | 2,56k | - |
| 2026-04-24 | Mr. Roop K. LakkarajuExec. VP & CFO | 658,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,56k | 34,52% |
| 2026-04-24 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | -77,00 | 22,16k | Derivative Exercise and Sale | 287,84 | 750,00 | - |
| 2026-04-24 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | 109,00 | 0,00 | Derivative Exercise and Retained Stock | - | 750,00 | 17,00% |
| 2026-04-21 | Mr. Gregory K. HinckleyLead Independent Director | 407,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,22k | 50,37% |
| 2026-04-21 | Ms. Melinda Litherland PeiIndependent Director | 407,00 | 0,00 | Derivative Exercise and Retained Stock | - | 715,00 | 132,14% |
| 2026-04-21 | Mr. Jeffrey L. EdwardsIndependent Director | 407,00 | 0,00 | Derivative Exercise and Retained Stock | - | 715,00 | 132,14% |
| 2026-04-21 | Mr. Arnold A. PinkstonIndependent Director | 407,00 | 0,00 | Derivative Exercise and Retained Stock | - | 715,00 | 132,14% |
| 2025-11-06 | Mr. James J. BarryExec. VP & President of Life Science Group | -699,87 | 214,29k | Verkauf | 306,18 | 510,00 | -57,85% |
| 2025-10-24 | Mr. Jonathan P. DiVincenzoPresident & COO | 919,00 | 0,00 | Derivative Exercise and Retained Stock | - | 919,00 | - |
| 2025-10-24 | Mr. Jonathan P. DiVincenzoPresident & COO | -950,00 | 322,76k | Derivative Exercise and Sale | 339,75 | 919,00 | - |
| 2025-10-20 | Mr. Sedat EvranExec. VP of Global Supply Chain | 709,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,23k | 46,52% |
| 2025-10-20 | Mr. Sedat EvranExec. VP of Global Supply Chain | -335,00 | 107,84k | Derivative Exercise and Sale | 321,90 | 2,23k | - |
| 2025-09-06 | Mr. Sedat EvranExec. VP of Global Supply Chain | 587,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,52k | 62,65% |
| 2025-09-06 | Mr. Sedat EvranExec. VP of Global Supply Chain | -277,00 | 81,83k | Derivative Exercise and Sale | 295,43 | 1,52k | - |
| 2025-09-06 | Mr. Roop K. LakkarajuExec. VP & CFO | 985,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,84k | 114,67% |
| 2025-09-06 | Mr. Roop K. LakkarajuExec. VP & CFO | -550,00 | 162,49k | Derivative Exercise and Sale | 295,43 | 1,84k | - |
| 2025-09-06 | Ms. Colleen CoreyInsider | 367,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,55k | 1,91% |
| 2025-09-06 | Ms. Colleen CoreyInsider | -209,00 | 61,74k | Derivative Exercise and Sale | 295,43 | 19,55k | - |
| 2025-09-06 | Ms. Allison SchwartzDirector | 59,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,46k | 4,22% |
| 2025-09-06 | Ms. Allison SchwartzDirector | -33,00 | 9,75k | Derivative Exercise and Sale | 295,43 | 1,46k | - |
| 2025-09-06 | Mr. James J. BarryExec. VP & President of Life Science Group | 678,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,21k | 127,44% |
| 2025-09-06 | Mr. James J. BarryExec. VP & President of Life Science Group | -378,00 | 111,67k | Derivative Exercise and Sale | 295,43 | 1,21k | - |
| 2025-09-06 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | 739,00 | 0,00 | Derivative Exercise and Retained Stock | - | 896,00 | 470,70% |
| 2025-09-06 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | -413,00 | 122,01k | Derivative Exercise and Sale | 295,43 | 896,00 | - |
| 2025-09-06 | Mr. Norman D. SchwartzChairman & CEO | 1,93k | 0,00 | Derivative Exercise and Retained Stock | - | 807,08k | 0,24% |
| 2025-09-06 | Mr. Norman D. SchwartzChairman & CEO | -1,53k | 451,42k | Derivative Exercise and Sale | 295,43 | 807,08k | - |
| 2025-09-06 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | 493,00 | 0,00 | Derivative Exercise and Retained Stock | - | - | - |
| 2025-09-06 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | -275,00 | 81,24k | Derivative Exercise and Sale | 295,43 | - | - |
| 2025-09-01 | Ms. Allison SchwartzDirector | 92,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,40k | 7,05% |
| 2025-09-01 | Ms. Allison SchwartzDirector | -55,00 | 16,38k | Derivative Exercise and Sale | 297,88 | 1,40k | - |
| 2025-09-01 | Mr. James J. BarryExec. VP & President of Life Science Group | 385,00 | 0,00 | Derivative Exercise and Retained Stock | - | 532,00 | 261,90% |
| 2025-09-01 | Mr. James J. BarryExec. VP & President of Life Science Group | -217,00 | 64,64k | Derivative Exercise and Sale | 297,88 | 532,00 | - |
| 2025-09-01 | Ms. Colleen CoreyInsider | 704,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,18k | 3,81% |
| 2025-09-01 | Ms. Colleen CoreyInsider | -398,00 | 118,56k | Derivative Exercise and Sale | 297,88 | 19,18k | - |
| 2025-09-01 | Mr. Norman D. SchwartzChairman & CEO | 3,27k | 0,00 | Derivative Exercise and Retained Stock | - | 805,15k | 0,41% |
| 2025-09-01 | Mr. Norman D. SchwartzChairman & CEO | -3,08k | 918,66k | Derivative Exercise and Sale | 297,88 | 805,15k | - |
| 2025-07-25 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | 157,00 | 0,00 | Derivative Exercise and Retained Stock | - | 157,00 | - |
| 2025-07-25 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | -88,00 | 23,25k | Derivative Exercise and Sale | 264,19 | 157,00 | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
